Spanish Biotech Stock News

Almirall (BME:ALM) has just put fresh numbers on the table, with Q4 2025 revenue of €288.9 million and basic EPS of €0.03 capping a trailing twelve month run that included total revenue of €1.1 billion and EPS of €0.22. Over the past year, revenue has been reported between €231.1 million and €288.9 million per quarter, while net income on a trailing basis reached €46.2 million, giving investors a clearer view of how the top line is converting into profit. With trailing net profit margin...

The European market has experienced a week of modest gains, with the pan-European STOXX Europe 600 Index reflecting improved sentiment due to easing geopolitical tensions and strong corporate earnings. However, potential tariff threats from the U.S. have introduced some uncertainty into the market's outlook. In such a fluctuating environment, stocks with high insider ownership can be appealing as they often indicate confidence from those closest to the company in its growth potential and...

As the pan-European STOXX Europe 600 Index navigates a week marked by geopolitical tensions and strong corporate earnings, investor sentiment remains cautiously optimistic. Amid this backdrop, small-cap stocks in Europe are gaining attention for their potential resilience and growth opportunities. Identifying promising stocks often involves looking for companies with robust fundamentals, innovative business models, or unique market positions that can thrive despite broader market volatility.

Shareholders might have noticed that Acerinox, S.A. ( BME:ACX ) filed its first-quarter result this time last week. The...

Puig Brands (BME:PUIG) is in focus after its Q1 2026 sales and trading statement call on 28 April, a key update that gives investors fresh insight into the beauty group’s recent operating trends. See our latest analysis for Puig Brands. The Q1 2026 update appears to have kept interest in the stock fairly steady, with a year to date share price return of 19.34% at a €17.71 share price and a 1 year total shareholder return of 5.56%, which suggests that earlier momentum has cooled recently. If...

In recent weeks, the pan-European STOXX Europe 600 Index has experienced modest gains amid easing geopolitical tensions and strong corporate earnings, despite pressures from potential U.S. tariff increases on EU goods. As investors navigate this landscape, growth companies with high insider ownership can be appealing due to their potential for alignment of interests between management and shareholders, offering a unique edge in today's market environment.

As the pan-European STOXX Europe 600 Index experiences modest gains amidst easing geopolitical tensions and strong corporate earnings, investors are keenly observing the potential impact of U.S. tariff threats on market dynamics. In this environment, identifying stocks with robust fundamentals and resilience to external pressures can be key to uncovering promising investment opportunities in Europe's evolving landscape.

Amadeus IT Group, S.A. ( BME:AMS ) just released its first-quarter report and things are looking bullish. The company...

Recent performance snapshot Ferrovial (BME:FER) has seen mixed share performance recently, with the stock roughly flat over the past month but easing around 3% over the past 3 months, despite a 40% total return over the past year. For investors tracking the longer picture, Ferrovial has also delivered very large total returns over the past 3 and 5 years, while more recent daily and weekly moves have been relatively modest by comparison. See our latest analysis for Ferrovial. With the share...

Q1 earnings give investors fresh data point on Prosegur Compañía de Seguridad (BME:PSG) Prosegur Compañía de Seguridad (BME:PSG) has just released first quarter 2026 results, reporting sales of €1,274 million and net income of €33 million, compared with €1,255 million and €28 million a year earlier. See our latest analysis for Prosegur Compañía de Seguridad. The stock is trading at €2.74, with a 1 day share price return of 2.05% and a year to date share price return of 6.41%. The 3 year total...

Why Construcciones y Auxiliar de Ferrocarriles (BME:CAF) is on investors’ radar after Q1 earnings Construcciones y Auxiliar de Ferrocarriles (BME:CAF) has drawn fresh attention after reporting first quarter 2026 results, with sales of €1,158 million and net income of €40 million compared with €1,118 million and €36 million a year earlier. See our latest analysis for Construcciones y Auxiliar de Ferrocarriles. The earnings release has arrived alongside a clear upswing in sentiment, with a...

Soft earnings didn't appear to concern Secuoya, Grupo de Comunicación, S.A.'s ( BME:SEC ) shareholders over the last...

Indra Sistemas, S.A. ( BME:IDR ) just reported healthy earnings but the stock price didn't move much. Our analysis...

Investors may be wondering if Ferrovial stock still offers value after a strong run, or if the current price now reflects most of the potential upside. The share price last closed at €59.90, with returns of 2.5% over the past week, 0.2% over the past month, 8.2% year to date and 39.8% over the last year. The 3-year and 5-year returns stand at 118.5% and 167.8% respectively. Those returns sit against a backdrop of ongoing interest in infrastructure and construction companies. Investors are...

Market shock puts Distribuidora Internacional de Alimentación (BME:DIA) under intense scrutiny Distribuidora Internacional de Alimentación (BME:DIA) is under pressure after a very sharp collapse in its stock price reportedly wiped out over $1.2b in market value, putting its debt and liquidity position in focus for investors. See our latest analysis for Distribuidora Internacional de Alimentación. Even after the recent collapse, DIA’s latest share price of €39.65 sits against a 1 year total...

Repsol (BME:REP) is back in focus after reporting first quarter 2026 results, with sales of €15,502 million and net income of €929 million, while reaffirming its 2026 production guidance. See our latest analysis for Repsol. At a share price of €22.05, Repsol has a 90 day share price return of 31.29% and a year to date share price return of 34.37%, while the 1 year total shareholder return of 107.19% points to strong momentum built over a longer period. If this kind of move has you thinking...

Why the latest earnings update matters for Meliá Hotels International (BME:MEL) Meliá Hotels International (BME:MEL) released first quarter 2026 earnings, with sales of €308.1 million and revenue of €461.6 million, compared with €303.9 million and €444.5 million a year earlier. This earnings update gives you fresh information on how the hotel operator’s business is performing across its owned, leased, managed, and franchised properties in Spain, America, EMEA, and Asia. See our latest...

Iberdrola (BME:IBE) opened the first quarter of 2026 with earnings that showed lower sales, net income, and basic EPS compared with a year earlier. This shift naturally puts the stock under closer review. See our latest analysis for Iberdrola. The first quarter earnings setback comes after a softer 30 day share price return of a 4.07% decline and a modest 90 day share price gain of 0.46%. However, Iberdrola’s 1 year total shareholder return of 29.63% and 5 year total shareholder return of...

Latest FY 2025 earnings snapshot Amadeus IT Group (BME:AMS) has just wrapped up FY 2025 with fourth quarter revenue of €1.6b and basic EPS of €0.57, alongside net income of €247.5m, while on a trailing twelve month basis revenue stood at €6.5b and EPS at €3.04. Over recent periods the company has seen revenue move from €6.1b on a trailing basis at the end of Q4 2024 to €6.5b by Q4 2025, with EPS shifting from €2.87 to €3.04 over the same span, setting up the current release against...

Grifols (BME:GRF) opened Q1 2026 with revenue of €1.7b and net income of €73m, translating into basic EPS of €0.11, while the trailing 12 month figures show revenue of €7.4b, net income of €415m and EPS of €0.61. The company has seen quarterly revenue move across a range from €1.79b in Q1 2025 to €1.98b in Q4 2025, with basic EPS figures of €0.10 in Q4 2024 and €0.14 in Q4 2025 before landing at €0.11 this quarter. This puts margins and earnings quality at the center of the discussion for...

Despite posting some strong earnings, the market for Pharma Mar, S.A.'s ( BME:PHM ) stock hasn't moved much. We did...

Meliá Hotels International (BME:MEL) has just wrapped up FY 2025 with fourth quarter revenue of €469.9 million and basic EPS of €0.09, capping a trailing twelve month run of €2.1 billion in revenue and EPS of €0.77, alongside an 8.2% net margin compared with 7% a year earlier. Over the past few quarters, revenue has ranged from €444.5 million to €616.6 million with quarterly EPS between €0.03 and €0.34, giving you a clear view of how the earnings power has built through the year. With margins...

Laboratorio Reig Jofre (BME:RJF) has just wrapped up FY 2025 with fourth quarter revenue of €94.7m and net income of €3.1m, translating to Basic EPS of €0.04. The trailing 12 month figures show revenue of €336.7m and net income of €5.0m, with Basic EPS of €0.06. Over recent quarters, revenue has ranged from €72.8m to €94.7m, and quarterly net income has moved between a loss of €2.1m and a profit of €3.7m. This sets up a picture where investors are likely to focus on how consistent margins...

This article examines whether Fluidra at €19.23 is a bargain or fairly priced by exploring what the current market is implying about the stock's value. The share price has seen mixed returns, with a 3.3% decline over the last 7 days and a 10.0% decline over the past month, while the 3-year return sits at 22.9% and the 5-year return at a 31.4% decline. Recent coverage has focused on how Fluidra's share price performance compares with the broader machinery sector and how investor expectations...